EGFR and cervical cancer: Our present data show that Src/Abl inhibitor restores the expression of β-catenin to the undercoat membrane to act as a cell-cell molecule which can deregulate several genes including P-cadherin, fascin, Id-1, IGF-R1 and EGF-R; thus, these deregulations induce cell differentiation and consequently block cell invasion ability of these human cervical cancer cells.